Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P10515 1737 DLAT DLTA Colon adenocarcinoma Ubiquitination N K376 P10515 1737 DLAT DLTA Head and neck squamous cell carcinoma Acetylation N K387 P10515 1737 DLAT DLTA Head and neck squamous cell carcinoma Phosphorylation N S391 P10515 1737 DLAT DLTA Cryptorchidism Acetylation N K466 P10515 1737 DLAT DLTA Stomach adenocarcinoma Acetylation N K466 P10515 1737 DLAT DLTA Stomach cancer Acetylation N K466 P10515 1737 DLAT DLTA Cryptorchidism Ubiquitination N K466 P10515 1737 DLAT DLTA Stomach adenocarcinoma Ubiquitination N K466 P10515 1737 DLAT DLTA Cryptorchidism Ubiquitination N K473 P10515 1737 DLAT DLTA Stomach adenocarcinoma Ubiquitination N K473 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Esophageal carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Lung squamous cell carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Phosphorylation N S40 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Ubiquitination N K44 Q16236 4780 NFE2L2 NRF2 Hepatocellular carcinoma Ubiquitination N K64 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Ubiquitination N K64 Q16236 4780 NFE2L2 NRF2 Stomach adenocarcinoma Phosphorylation N S215 Q16236 4780 NFE2L2 NRF2 Kidney renal papillary cell carcinoma Phosphorylation N S344 Q16236 4780 NFE2L2 NRF2 Rectum adenocarcinoma Phosphorylation N S344 Q16236 4780 NFE2L2 NRF2 Skin cutaneous melanoma Phosphorylation N S344 Q16236 4780 NFE2L2 NRF2 Rectum adenocarcinoma Phosphorylation N S347 Q16236 4780 NFE2L2 NRF2 Skin cutaneous melanoma Phosphorylation N S347 Q16236 4780 NFE2L2 NRF2 Rectum adenocarcinoma Phosphorylation N S351 Q16236 4780 NFE2L2 NRF2 Skin cutaneous melanoma Phosphorylation N S351 Q16236 4780 NFE2L2 NRF2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S374 Q16236 4780 NFE2L2 NRF2 Lung squamous cell carcinoma Phosphorylation N S374 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Phosphorylation N S408 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Acetylation N K443 Q16236 4780 NFE2L2 NRF2 Stomach adenocarcinoma Acetylation N K445 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Acetylation N K445 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Acetylation N K462 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Ubiquitination N K462 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K506 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K508 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K516 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K518 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma Acetylation N K518 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma SUMOylation N K518 Q16236 4780 NFE2L2 NRF2 Lung adenocarcinoma SUMOylation N K518 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K533 Q16236 4780 NFE2L2 NRF2 Uterine carcinosarcoma Acetylation N K533 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K536 Q16236 4780 NFE2L2 NRF2 Uterine carcinosarcoma Acetylation N K536 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K538 Q16236 4780 NFE2L2 NRF2 Uterine carcinosarcoma Acetylation N K538 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Acetylation N K555 Q16236 4780 NFE2L2 NRF2 Pheochromocytoma and Paraganglioma Acetylation N K555 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N S558 Q16236 4780 NFE2L2 NRF2 Pheochromocytoma and Paraganglioma Phosphorylation N S558 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Phosphorylation N S558 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N T559 Q16236 4780 NFE2L2 NRF2 Pheochromocytoma and Paraganglioma Phosphorylation N T559 Q16236 4780 NFE2L2 NRF2 Uterine corpus endometrial carcinoma Phosphorylation N T559 Q16236 4780 NFE2L2 NRF2 Colon adenocarcinoma Ubiquitination N K574 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Ubiquitination N K574 Q16236 4780 NFE2L2 NRF2 Colon adenocarcinoma Phosphorylation N Y576 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N Y576 Q16236 4780 NFE2L2 NRF2 Colon adenocarcinoma Phosphorylation N S577 Q16236 4780 NFE2L2 NRF2 Head and neck squamous cell carcinoma Phosphorylation N S577 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K596 Q16236 4780 NFE2L2 NRF2 Breast adenocarcinoma Acetylation N K596 Q16236 4780 NFE2L2 NRF2 Bladder urothelial carcinoma Acetylation N K599 Q16236 4780 NFE2L2 NRF2 Breast adenocarcinoma Acetylation N K599 Q16236 4780 NFE2L2 NRF2 Esophageal squamous cell carcinoma tumor tissue Phosphorylation P 33390848 Q16236 4780 NFE2L2 NRF2 Cervical cancer tumor tissue Deubiquitination U 36527747 Q16236 4780 NFE2L2 NRF2 Clear cell renal cell carcinoma ccRCC tissue Ubiquitination D 32128917 Q16236 4780 NFE2L2 NRF2 Gastric cancer tumor tissue Ubiquitination D 32605589 Q16236 4780 NFE2L2 NRF2 Liver ischemia/reperfusion injury hepatocytes Threonine phosphorylation U T369 35108418 Q16236 4780 NFE2L2 NRF2 Colon cancer colon tumor tissues Acetylation U K438 36442525 P10515 1737 DLAT DLTA Clear cell renal cell carcinoma ccRCC tissues Lipoylation D 38169635 P10515 1737 DLAT DLTA Primary liver cancer tumor tissues Lipoylation D 37277863 P10515 1737 DLAT DLTA Thyroid cancer thyroid cancer tissues Lipoylation D 37554785 Q16236 4780 NFE2L2 NRF2 Melanoma melanoma cells Glutarylation D 36050469 Q16236 4780 NFE2L2 NRF2 Clear cell renal cell carcinoma ccRCC tissues Phosphorylation U 32128917 P10515 1737 DLAT DLTA Cancer CD8+ T cells Glutarylation D K259 37605057 P10515 1737 DLAT DLTA Cancer CD8+ T cells Glutarylation D K396 37605057 P10515 1737 DLAT DLTA Cancer CD8+ T cells Glutarylation D K482 37605057 P10515 1737 DLAT DLTA Diabetes Lipoylation D 36675183 Q16236 4780 NFE2L2 NRF2 Keratoconus Serine phosphorylation D S40 36240204 Q16236 4780 NFE2L2 NRF2 Kaposi's sarcoma Serine phosphorylation U S40 25505069;25340789 Q16236 4780 NFE2L2 NRF2 Hepatocellular carcinoma SUMOylation P K110 31546024